Jonathan D. Wright, Ph.D.
Affiliations: | University of Pennsylvania, Philadelphia, PA, United States |
Area:
phonetics, phonology, computational linguisticsGoogle:
"Jonathan Wright"Parents
Sign in to add mentorMark Y. Liberman | grad student | 2007 | Penn | |
(Laryngeal contrast in Seoul Korean.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
de Jong JJ, Boormans JL, van Rhijn BWG, et al. (2020) Distribution of Molecular Subtypes in Muscle-invasive Bladder Cancer Is Driven by Sex-specific Differences. European Urology Oncology |
Nyame Y, Wang X, Jordahl K, et al. (2020) Pd52-05 Assessing Pam50 Molecular Subtypes By Race And Outcomes In Men With Localized Prostate Cancer The Journal of Urology. 203 |
Nyame Y, Holt S, Winters B, et al. (2019) Pd57-06 Neoadjuvant Chemotherapy Utilization In Muscle-Invasive Bladder Cancer: Associations Between Socioeconomic Status, Ethnicity, And Utilization? The Journal of Urology. 201 |
Costa JBD, Gibb EA, Bivalacqua TJ, et al. (2019) Molecular characterization of neuroendocrine-like bladder cancer European Urology Supplements. 18 |
Lotan Y, Wright J, Dall'Era MA, et al. (2018) MP58-19 A GENOMIC CLASSIFIER FOR IDENTIFYING A NEUROENDOCRINE-LIKE BLADDER CANCER SUBTYPE Journal of Urology. 199 |
Lam H, Liu Y, Vakar-Lopez F, et al. (2018) Mp54-14 Characterization Of Human Bladder Cancer Patient-Derived Xenograft In Vivo And In Organoids The Journal of Urology. 199 |
Seiler R, Ashab HA, Erho N, et al. (2017) Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy. European Urology |
Seiler R, Ashab H, Erho N, et al. (2017) Muscle invasive bladder cancer: A single sample patient assay to predict molecular subtypes and benefit of neoadjuvant chemotherapy European Urology Supplements. 16: e1567-e1568 |
Seiler R, Gibb EA, Takhar M, et al. (2017) Plasticity in muscle-invasive bladder cancer before and after cisplatin-based neoadjuvant chemotherapy Urologic Oncology: Seminars and Original Investigations. 35: 618 |
Winters B, Kearns J, Holt S, et al. (2017) Mp80-05 Is There Benefit To Adjuvant Radiation In Stage Iii Penile Cancer After Lymph Node Dissection? Findings From The National Cancer Database. The Journal of Urology. 197 |